CLEU
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
Clearleaf US (CLEU) has been given a Neutral rating within the respected band according to the latest evaluation. This reflects a composite score of 36.5 with moderate conviction of 3/5. Among the four pillars—fundamentals, regulatory, market, and editorial—the regulatory environment emerged as the prime contributor with a score of 50.0, signifying relative stability within its LATAM jurisdiction. Conversely, the fundamentals pillar lags with a score of 27.0, illustrating a need for improvement in financial metrics.
From available data, CLEU's fundamentals appear particularly strained. The company is experiencing a significant year-over-year revenue decline. However, the gross margin remains robust, allowing room for potential financial re-engineering. Concerns persist with regard to profitability, as indicated by a negative operating margin and sizeable negative EBITDA, alongside a cash burn ratio that suggests limited runway before additional capital may be required. These dynamics contribute to a broader stretched financial condition. Regulatory scores benefit from CLEU’s unblemished enforcement record and satisfactory jurisdictional posture, despite ongoing issues with filing cadence contributing to lower regulatory cadence subscores.
Looking forward, the most critical aspect to monitor involves the regulatory pillar, given its dominant influence on the overall rating. A strengthening regulatory posture in LATAM may provide a framework for operational stability and growth prospects. Enhanced adherence to regulatory filings and improvements in the jurisdiction's posture could further reinforce CLEU's positioning. With the regulatory environment continuing to drive the composite score, stakeholders should prioritize observing any changes or developments in LATAM regulatory policy closely.
- IR email
- nza@clearagro.com
- IR page
- Investor relations
- CEO
- Lawrence Pratt
- CFO
- Alejandro Martínez Soto
- Website
- Company website
- Market cap
- $3.5M
- Enterprise value
- $-81.6M
- Price to book
- 0.00
- Price to sales
- 1.44
- EV / EBITDA
- 10.75
- Revenue (TTM)
- $2.4M
- Gross profit (TTM)
- $1.5M
- EBITDA
- $-5.0M
- Operating margin
- -520.8%
- Profit margin
- 0.0%
- Rev growth YoY
- -34.8%
- Return on equity
- -10.5%
- Return on assets
- -3.3%
- EPS (TTM)
- $-4079.38
- Shares outstanding
- 3.4M
- Insider ownership
- 1.5%
- Institutional ownership
- 1.4%
- Beta
- 1.84
- Full-time employees
- 63
- GICS sector
- Consumer Defensive
- GICS industry
- Education & Training Services
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for CLEU (CLEU)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for CLEU (CLEU), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for CLEU are maintained by Cannabis Investor News and refreshed throughout the trading day.